Literature DB >> 23483832

Clinical correlations in cerebral palsy.

Ioana Minciu1.   

Abstract

BACKGROUND: Cerebral palsy (CP) is a group of persistent (but not necessarily unchanged), movement, posture, muscle tone and motor skills disorders non-progressive, with early onset, due to non-progressive impairments, occurring on an immature brain or a brain under development (prenatal, perinatal, postnatal during the first 3-4 years of life). It is associated to a variable extent with: cognitive disorders, epilepsy, sensory deficits, behaviour disorders. AIM: The study of the correlations between the clinical forms/subtypes of CP, comorbidities, and severity of functional impairment. MATERIAL AND
METHOD: It is a retrospective trial aimed only at patients with the diagnosis of cerebral palsy admitted at Paediatric Neurology Clinic of the "Alexandru Obregia" Clinical Hospital in 2010.Results, discussions and conclusions: Patients with cerebral palsy corresponding with the criteria for inclusion: 379. The spastic CP type has prevailed. Comorbidities like mental retardation, epilepsy, and ophthalmic disorders were found with greater frequency than in the studies in the literature.The unilateral spastic form was statistically correlated with slight functional impairment (GMFCS I), with the absence of comorbidities or mild mental retardation, or with focal epilepsy when there is epilepsy. The bilateral spastic, tetraparetic and dyskinetic forms were correlated significantly with severe functional impairment (GMFCS IV, V), with profound or severe retardation, microcephaly, swallowing disorders, statural, ponderal hypotrophy, blindness and epilepsy. The bilateral spastic paraparetic form, which in the literature is mentioned as having fewer associated disorders (for example strabismus, slight retardation), when there is severe functional impairment, it may have the same comorbidities as the tetraparetic form (similar to the cases studied in the hospital). Comorbidities are the main admission cause and it correlates with the severity and prognosis.

Entities:  

Keywords:  GMFCS; cerebral palsy; clinical type; comorbidities

Year:  2012        PMID: 23483832      PMCID: PMC3593283     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  15 in total

Review 1.  The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: a systematic review.

Authors:  Ingeborg Krägeloh-Mann; Veronka Horber
Journal:  Dev Med Child Neurol       Date:  2007-02       Impact factor: 5.449

2.  Development and reliability of a system to classify gross motor function in children with cerebral palsy.

Authors:  R Palisano; P Rosenbaum; S Walter; D Russell; E Wood; B Galuppi
Journal:  Dev Med Child Neurol       Date:  1997-04       Impact factor: 5.449

Review 3.  Population-based study of neuroimaging findings in children with cerebral palsy.

Authors:  Kayle Towsley; Michael I Shevell; Lynn Dagenais
Journal:  Eur J Paediatr Neurol       Date:  2011-01       Impact factor: 3.140

4.  The prevalence of cerebral visual disturbance in children with cerebral palsy.

Authors:  A J Schenk-Rootlieb; O van Nieuwenhuizen; Y van der Graaf; D Wittebol-Post; J Willemse
Journal:  Dev Med Child Neurol       Date:  1992-06       Impact factor: 5.449

5.  MRI features of cerebral lesions and cognitive functions in preterm spastic diplegic children.

Authors:  E Fedrizzi; M Inverno; M G Bruzzone; G Botteon; V Saletti; M Farinotti
Journal:  Pediatr Neurol       Date:  1996-10       Impact factor: 3.372

6.  Bilateral lesions of thalamus and basal ganglia: origin and outcome.

Authors:  Ingeborg Krägeloh-Mann; Alexandra Helber; Irina Mader; Martin Staudt; Markus Wolff; Floris Groenendaal; Linda DeVries
Journal:  Dev Med Child Neurol       Date:  2002-07       Impact factor: 5.449

7.  Clinical and aetiological aspects of epilepsy in children with cerebral palsy.

Authors:  Malin Carlsson; Gudrun Hagberg; Ingrid Olsson
Journal:  Dev Med Child Neurol       Date:  2003-06       Impact factor: 5.449

8.  Epilepsy in children with cerebral palsy.

Authors:  K L Kwong; S N Wong; K T So
Journal:  Pediatr Neurol       Date:  1998-07       Impact factor: 3.372

9.  Etiologic yield of cerebral palsy: a contemporary case series.

Authors:  Michael I Shevell; Annette Majnemer; Isabelle Morin
Journal:  Pediatr Neurol       Date:  2003-05       Impact factor: 3.372

10.  Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  S Ashwal; B S Russman; P A Blasco; G Miller; A Sandler; M Shevell; R Stevenson
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

View more
  5 in total

Review 1.  Long-term neurodevelopmental outcomes after preterm birth.

Authors:  Farin Soleimani; Farzaneh Zaheri; Fatemeh Abdi
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

2.  Stability and migration across femoral varus derotation osteotomies in children with neuromuscular disorders.

Authors:  Peter Buxbom; Stig Sonne-Holm; Niels Ellitsgaard; Christian Wong
Journal:  Acta Orthop       Date:  2016-11-28       Impact factor: 3.717

3.  Stakeholder Perspectives on Engaging With Cerebral Palsy Research Studies After Onset of COVID-19 in the United States.

Authors:  Divya Joshi; Nayo Hill; Alexandra Hruby; Shreya Viswanathan; Carson Ingo; Heidi Roth; Theresa Sukal-Moulton
Journal:  Arch Phys Med Rehabil       Date:  2021-03-10       Impact factor: 4.060

4.  Challenges of brain-computer interface facilitated cognitive assessment for children with cerebral palsy.

Authors:  Jane E Huggins; Petra Karlsson; Seth A Warschausky
Journal:  Front Hum Neurosci       Date:  2022-09-20       Impact factor: 3.473

5.  Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy.

Authors:  Geeta Shroff; Anupama Gupta; Jitender Kumar Barthakur
Journal:  J Transl Med       Date:  2014-12-12       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.